<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04218591</url>
  </required_header>
  <id_info>
    <org_study_id>PRP vs placebo</org_study_id>
    <nct_id>NCT04218591</nct_id>
  </id_info>
  <brief_title>A Study on the Effect of Platelet Rich Plasma (PRP) on Osteoarthritis in the Thumb Base</brief_title>
  <official_title>A Study on the Effect of Platelet Rich Plasma (PRP) on Osteoarthritis in the Thumb Base</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized comparison between Platelet Rich Plasma (PRP) and placebo (Saline) for thumb
      base.osteoarthritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patient-rated pain on load</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Numerical rating scale 0-10p (10=worst possible pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Nelson Thumb score</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Patient Rated Outcome Measure, 0-100p, lower score= more disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-5D</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Weight mean value: 0=dead, 1= healthy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient-rated Wrist and Hand Evaluation (PRWHE)</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Patient Rated Outcome Measure 0-100p, higher score=more disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Disability of the Hand, Arm and Shoulder (DASH) score</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Patient Rated Outcome Measure, 0-100p higher score=more disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hospital Anxiety and Depression Score (HADS),</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>2 subscores for anxiety (0-21p) and depression (0-21p), higher score = worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pain Catastrophizing Score (PCS).</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>0-52p, higher score = more pain catastrophizing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in thumb range of motion</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Radial and palmar abduction of the first metacarpal (degrees)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in thumb strength</measure>
    <time_frame>3 and 6 months after injection.</time_frame>
    <description>Key pinch and pinch strength (Kg)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Thumb Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>PRP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-articular injection PRP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intra-articular injection Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PRP</intervention_name>
    <description>Platelet rich plasma</description>
    <arm_group_label>PRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Arthritis in the thumb base.

          -  Radiological Eaton Littler class 1-3.

          -  Clinical signs of thumb base osteoarthritis: pain at palpation of the CMC-1 joint and
             pain during provocation/grinding test.

        Exclusion Criteria:

          -  Rheumatoid arthritis.

          -  Ongoing infection in the hand or wrist.

          -  History of gout or pseudo gout.

          -  Inability to co-operate with the follow-up protocol (language difficulties, severe
             psychiatric disorder, cognitive impairment, drug addiction).

          -  Intra-articular injection in the affected joint within 6 months.

          -  Eaton Littler class 4 (STT joint involved).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Wilcke, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Wilcke, MD PhD</last_name>
    <phone>0708294613</phone>
    <phone_ext>0708294613</phone_ext>
    <email>maria.wilcke@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kajsa Evans, MD</last_name>
    <email>kajsa.evans@sll.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Hand Surgery SÃ¶dersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>S-11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Wilcke, PhD</last_name>
      <phone>+46708294613</phone>
      <email>maria.wilcke@sll.se</email>
    </contact>
    <contact_backup>
      <last_name>Johanna Von Kieseritzky, PhD</last_name>
      <email>johanna.vonkieseritzky@sll.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 19, 2019</study_first_submitted>
  <study_first_submitted_qc>January 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2020</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Maria Wilcke</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

